The Department of Surgery welcomes Angela Carter, Ph.D., to the Division of Gastrointestinal Surgery and the laboratory of Dr. Aurelio Galli, as an instructor.

Before becoming an instructor, Dr. Carter studied neuroendocrine cancer as a postdoctoral fellow at UAB in the laboratory of Dr. James Bibb. She will continue research with the neuroendocrine team, integrating these studies into new responsibilities as a member of CINEMA and the Galli Lab.

Carter received a B.S. in Biology and Chemistry from Southeastern Oklahoma State University and a Ph.D. in Cellular Signaling, with an emphasis in Pharmacology, from the University of Texas Southwestern Medical Center. Her doctoral work was performed in the laboratory of Dr. Paul Sternweis where she studied regulatory mechanisms of GTPases, delineating contributions of catalytic activation versus subcellular localization.

Carter’s postdoctoral work was funded by the American Cancer Society and focused on identifying biomarkers with the capacity to predict tumor response to select targeted therapeutics and the development of novel animal models of neuroendocrine cancer. Her current research interests involve delineating tumorigenic signaling pathways, studying mechanisms of hormone/neurotransmitter release, investigating tumor-derived hormonal induction of gastrointestinal disease, and engineering symbiotic organisms for therapeutic use.

“We’re delighted that Dr. Carter has joined our team as an instructor,” said Aurelio Galli, Ph.D., D.Sc., professor, director for gastrointestinal biology research, and co-director of CINEMA. “Dr. Carter will continue to represent UAB Surgery on a national stage through her great strides in inter-systemic research.”